Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
主要な著者: | , , , , , , |
---|---|
フォーマット: | Conference item |
出版事項: |
American Thoracic Society
2018
|